<?xml version="1.0" encoding="UTF-8" ?>
<Journal>
<Journal-Info>
<name>PHARMANEST : An International Journal of Advances in Pharmaceutical Sciences</name>
<website>pharmanest.net</website>
<email>pharmanest@gmail.com</email>
<issn mediatype='print'> 2453-7005 Online: 2343-212X</issn>
<issn mediatype='Online'></issn>
</Journal-Info>
<article>
<title>CHELATION THERAPY</title>
<authors>G.K.SUDHAKAR*, VENKATESH KAMATH B, ARAVIND PAI,VASUDEV PAI</authors>
<keywords>Chelating agents, Lead poisoning, Wilson?s disease, Iron poisoning, Thalassemia.</keywords>
<pages>1458-1463</pages>
<issue_number>Volume 4, Issue 6</issue_number>
<issue_period>November - December 2013</issue_period>
<abstract>Chelating agents are drugs that complex with and thereby hold metal ions in inactive form that are suitable for mobilization and subsequent excretion. The principal therapeutic use of chelating agent is to treat heavy metal poisoning. This article describes a list of six chelating agents commonly employed in clinical practice.</abstract>
</article>
</Journal>
